Clinical Trial Results
Search
Dr. Frank Harrell and Dr. C. Michael Gibson talk about the FDA’s new draft guidance on using Bayesian methods in clinical trials—and it could be a game changer.
By allowing researchers to combine prior data with new trial results, these approaches can speed up decision-making, reduce costs, and […]
Dr. Ola Akinboboye and Dr. C. Michael Gibson discuss his recent publication showing that acoramidis has similar efficacy in wild-type and variant transthyretin amyloid cardiomyopathy
Sponsored by an independent educational grant from BridgeBio Pharma Inc.
Dr. Nick Nurmohamed and Dr. C. Michael Gibson discuss the new concept of Staging Atherosclerosis, where the type (high risk fatty) and the extent of both obstructive and non-obstructive atherosclerosis in the coronary wall is classified as 0-4 (rather than just saying narrowing’s are present) and how this improves risk stratification.
Sponsored by Cleerly, Women as One, and International Atherosclerosis Society